84 related articles for article (PubMed ID: 11952141)
21. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human hepsin as novel targets for prostate cancer immunotherapy.
Guo J; Li G; Tang J; Cao XB; Zhou QY; Fan ZJ; Zhu B; Pan XH
Scand J Immunol; 2013 Sep; 78(3):248-57. PubMed ID: 23721092
[TBL] [Abstract][Full Text] [Related]
22. Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
Kelleher AD; Booth BL; Sewell AK; Oxenius A; Cerundolo V; McMichael AJ; Phillips RE; Price DA
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1063-6. PubMed ID: 11485623
[No Abstract] [Full Text] [Related]
23. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
24. Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope.
Wölfel C; Drexler I; Van Pel A; Thres T; Leister N; Herr W; Sutter G; Huber C; Wölfel T
Int J Cancer; 2000 Nov; 88(3):432-8. PubMed ID: 11054673
[TBL] [Abstract][Full Text] [Related]
25. The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65.
Charo J; Geluk A; Sundbäck M; Mirzai B; Diehl AD; Malmberg KJ; Achour A; Huriguchi S; van Meijgaarden KE; Drijfhout JW; Beekman N; van Veelen P; Ossendorp F; Ottenhoff TH; Kiessling R
Eur J Immunol; 2001 Dec; 31(12):3602-11. PubMed ID: 11745380
[TBL] [Abstract][Full Text] [Related]
26. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
[TBL] [Abstract][Full Text] [Related]
27. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
Sewell AK; Harcourt GC; Goulder PJ; Price DA; Phillips RE
Eur J Immunol; 1997 Sep; 27(9):2323-9. PubMed ID: 9341776
[TBL] [Abstract][Full Text] [Related]
28. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
29. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
30. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
31. Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes.
Schmitt M; Harrer E; Goldwich A; Bäuerle M; Graedner I; Kalden JR; Harrer T
AIDS; 2000 Apr; 14(6):653-8. PubMed ID: 10807188
[TBL] [Abstract][Full Text] [Related]
32. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
[TBL] [Abstract][Full Text] [Related]
33. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
Marsac D; Puaux AL; Rivière Y; Michel ML
Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
[TBL] [Abstract][Full Text] [Related]
34. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
35. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide.
Barouch D; Davenport M; McMichael A; Reay P
Int Immunol; 1995 Oct; 7(10):1599-605. PubMed ID: 8562505
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.
Gavioli R; Gallerani E; Fortini C; Fabris M; Bottoni A; Canella A; Bonaccorsi A; Marastoni M; Micheletti F; Cafaro A; Rimessi P; Caputo A; Ensoli B
J Immunol; 2004 Sep; 173(6):3838-43. PubMed ID: 15356131
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif.
Altfeld MA; Livingston B; Reshamwala N; Nguyen PT; Addo MM; Shea A; Newman M; Fikes J; Sidney J; Wentworth P; Chesnut R; Eldridge RL; Rosenberg ES; Robbins GK; Brander C; Sax PE; Boswell S; Flynn T; Buchbinder S; Goulder PJ; Walker BD; Sette A; Kalams SA
J Virol; 2001 Feb; 75(3):1301-11. PubMed ID: 11152503
[TBL] [Abstract][Full Text] [Related]
38. Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.
Castilleja A; Ward NE; O'Brian CA; Swearingen B; Swan E; Gillogly MA; Murray JL; Kudelka AP; Gershenson DM; Ioannides CG
Mol Cell Biochem; 2001 Jan; 217(1-2):21-33. PubMed ID: 11269662
[TBL] [Abstract][Full Text] [Related]
39. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
[TBL] [Abstract][Full Text] [Related]
40. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
